Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
International Journal of Urology : Official Journal of the Japanese Urological Association|December 20, 2013
Successful penile reconstruction after multimodal therapy in patients with primitive neuroectodermal tumor originating from the penisTomoshige Akino, Nobuo Shinohara, Kanako Hatanaka, et al.European Urology|November 14, 2006
Survival and prognostic classification of patients with metastatic renal cell carcinoma of boneYutaka Toyoda, Nobuo Shinohara, Toru Harabayashi, et al.Angiogenesis|July 30, 2013
GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2Silvia Coma, Marc Allard-Ratick, Tomoshige Akino, et al.Cancer Research|May 10, 2014
Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastomaTomoshige Akino, Xuezhe Han, Hironao Nakayama, et al.Journal of Medical Case Reports|September 2, 2023
Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case reportKazutaka Iijima, Toshizo Takayama, Satoko Shindo, et al.Oncotarget|September 15, 2018
Bladder cancer detection by urinary extracellular vesicle mRNA analysisTaku Murakami, Cindy M Yamamoto, Tomoshige Akino, et al.The Journal of Biological Chemistry|December 1, 2012
Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding proteinAkio Shimizu, Hironao Nakayama, Priscilla Wang, et al.Biochemical and Biophysical Research Communications|March 23, 2010
Isolated tumor endothelial cells maintain specific character during long-term cultureKohei Matsuda, Noritaka Ohga, Yasuhiro Hida, et al.The American Journal of Pathology|January 17, 2012
Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironmentKosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, et al.Japanese Journal of Clinical Oncology|June 26, 2018
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in JapanRyuji Matsumoto, Takashige Abe, Junji Ishizaki, et al.Pageof 2